The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines

By Wilson A.D.   Lovgren-Bengtsson K.   Villacres-Ericsson M.   Morein B.   Morgan A.J.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1282-1290

Elsevier

Access to resources Recommend Favorite

Peptide based cytotoxic T-cell vaccines; delivery of multiple epitopes, help, memory and problems

By Elliott S.L.   Pye S.   Le T.   Mateo L.   Cox J.   Macdonald L.   Scalzo A.A.   Forbes C.A.   Suhrbier A.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 2009-2019

Elsevier

Access to resources Recommend Favorite

Dendritic cell KLH loading requirements for efficient CD4 + T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines

By Millard A.L.   Ittelet D.   Schooneman F.   Bernard J.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 869-876

Elsevier

Access to resources Recommend Favorite

Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis

By Golovliov I.   Ericsson M.   akerblom L.   Sandstrom G.   Tarnvik A.   Sjostedt A.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 261-267

Elsevier

Access to resources Recommend Favorite

HIV T cell vaccines, the importance of clades

By McMichael A.   Mwau M.   Hanke T.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1918-1921

Elsevier

Access to resources Recommend Favorite